The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
Lunch ladies are getting a MAHA makeover. The Food and Drug Administration’s $17 million pilot program aimed at helping ...
The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss ...
The deal involves Regeneron lowering the prices of all its current and future drugs on Medicaid, according to Trump. It also involves selling a cholesterol drug called Praluent for $225 on the White ...
The US Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) have proposed a parallel ...
Demand for weight loss drugs is ballooning across the U.S. — and Amazon wants in. The Seattle-based tech giant launched its ...
Without big Medicare insurers, the future of program to cover popular obesity drugs had been in question.
The U.S. ‌Food and Drug Administration has approved Regeneron's gene therapy for ​a rare genetic form ​of deafness, the ...
When it comes to substance abuse or related, low-level crimes, traditionally, police officers’ only tools are citations or ...
B makes it possible for community health organizations to stretch scarce resources and reinvest savings where they belong — ...
The Centers for Medicare & Medicaid Services and the Food and Drug Administration April 23 announced a new pathway to ...